You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

  1. CORPORATE - 20-10-2020

    Kedrion Biopharma supports the launch of "Nature Italy"

    The Company reaffirms and strengthens its commitment to research and innovation

    read more 

  2. CORPORATE - 08-10-2020

    Kedrion alongside AICE on the 50th Ann. of the first AICE Triennial Conference

    The company supports the reading of a scientific study on the role of Factor VIII in the protection of the joints

    read more 

  3. CORPORATE - 06-10-2020

    Kedrion announces the appointment of a new CEO

    Val Romberg from the USA, one of the most esteemed managers in the industry

    read more 

  4. CORPORATE - 01-09-2020

    KEDPLASMA GmbH changes its name to Kedrion Biopharma GmbH

    Further step towards an even stronger focus on patients in Europe

    read more 

Pages

For more information please contact: pressoffice@kedrion.com